| Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer (NCT00293579) | Ohio State University Comprehensive Cancer Center | 2006-02-01 |
| Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy (NCT00442520) | University of Kansas Medical Center | 2006-02-01 |
| Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia (NCT00584129) | University of Alabama at Birmingham | 2006-02-01 |
| Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors (NCT00581906) | Memorial Sloan Kettering Cancer Center | 2006-02-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer (NCT00272181) | Sesen Bio, Inc. | 2006-01-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia (NCT00503776) | Vanderbilt-Ingram Cancer Center | 2006-01-01 |
| Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer (NCT00280891) | Alberta Health services | 2006-01-01 |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer (NCT00897793) | Vanderbilt-Ingram Cancer Center | 2006-01-01 |
| A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia (NCT00497406) | AHS Cancer Control Alberta | 2005-12-01 |
| Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer (NCT00412776) | Sesen Bio, Inc. | 2005-12-01 |
| S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx (NCT00268372) | SWOG Cancer Research Network | 2005-12-01 |
| Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer (NCT00176241) | Susanne Arnold | 2005-12-01 |
| Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00265941) | Radiation Therapy Oncology Group | 2005-11-01 |
| Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer (NCT00855764) | Bristol-Myers Squibb | 2005-10-01 |
| Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer (NCT00245349) | University of Iowa | 2005-10-01 |
| A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis (NCT00584597) | University of Oklahoma | 2005-10-01 |
| Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer (NCT00898300) | Radiation Therapy Oncology Group | 2005-09-01 |
| Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer (NCT00507858) | M.D. Anderson Cancer Center | 2005-09-01 |
| A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients (NCT00329589) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2005-09-01 |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT01172028) | University of Arizona | 2005-09-01 |
| Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis (NCT00334997) | University College London Hospitals | 2005-09-01 |
| Vaccine Therapy in Treating Patients With Head and Neck Cancer (NCT00404339) | Robert Ferris | 2005-09-01 |
| Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas (NCT00169221) | Groupe Oncologie Radiotherapie Tete et Cou | 2005-09-01 |
| Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer (NCT00527982) | M.D. Anderson Cancer Center | 2005-09-01 |
| Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00281840) | Case Comprehensive Cancer Center | 2005-09-01 |
| Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer (NCT00140556) | David M. Brizel, MD | 2005-08-01 |
| Head and Neck Cancer Registry (LORHAN) (NCT01080313) | Eli Lilly and Company | 2005-08-01 |
| Effects of Swallowing Therapy in Head and Neck Cancer (NCT00214305) | University of Wisconsin, Madison | 2005-08-01 |
| Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00425750) | Vanderbilt-Ingram Cancer Center | 2005-08-01 |
| Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer (NCT00101582) | Swedish Orphan Biovitrum | 2005-08-01 |
| Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer (NCT00281866) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-07-01 |
| Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET (NCT00180245) | Technische Universität Dresden | 2005-07-01 |
| S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer (NCT00084435) | SWOG Cancer Research Network | 2005-07-01 |
| Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules (NCT00316823) | University of California, San Francisco | 2005-07-01 |
| A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy (NCT00626639) | Swedish Orphan Biovitrum | 2005-07-01 |
| GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer (NCT00293462) | Marilyn Dodd | 2005-06-07 |
| Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer (NCT00509665) | Medical University of South Carolina | 2005-06-01 |
| Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy (NCT00559156) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-06-01 |
| Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients (NCT01172470) | University of Chicago | 2005-06-01 |
| Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation (NCT00577902) | University of Arkansas | 2005-06-01 |
| Study of Proteins in Head and Neck Cancer Cells (NCT00896948) | Vanderbilt University Medical Center | 2005-05-01 |
| Real-Time Internet Evaluation of Swallowing (NCT00580138) | University of Arkansas | 2005-05-01 |
| A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer (NCT00337532) | Bristol-Myers Squibb | 2005-05-01 |
| Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck (NCT00096174) | Eastern Cooperative Oncology Group | 2005-04-08 |
| Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer (NCT00113334) | M.D. Anderson Cancer Center | 2005-04-01 |
| Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma (NCT00040911) | Children's Oncology Group | 2005-04-01 |
| Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers (NCT00899769) | Vanderbilt University Medical Center | 2005-04-01 |
| Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00113347) | M.D. Anderson Cancer Center | 2005-04-01 |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery (NCT00113399) | Radiation Therapy Oncology Group | 2005-04-01 |
| Depression and Adherence in Head and Neck Cancer (NCT00498875) | M.D. Anderson Cancer Center | 2005-03-15 |
| Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer (NCT01147991) | Cancer Research UK | 2005-03-01 |
| Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer (NCT00897052) | Vanderbilt-Ingram Cancer Center | 2005-02-01 |
| Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer (NCT00256308) | University of California, Irvine | 2005-02-01 |
| 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00102635) | M.D. Anderson Cancer Center | 2005-01-20 |
| Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer (NCT00089297) | Eastern Cooperative Oncology Group | 2005-01-06 |
| Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer (NCT00248560) | Barbara Ann Karmanos Cancer Institute | 2005-01-01 |
| A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers (NCT00122239) | AHS Cancer Control Alberta | 2005-01-01 |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer (NCT00131638) | Amgen | 2005-01-01 |
| S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer (NCT00100789) | SWOG Cancer Research Network | 2005-01-01 |
| Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) (NCT00122460) | Merck KGaA, Darmstadt, Germany | 2004-12-01 |
| Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer (NCT00100828) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-11-01 |
| Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer (NCT00098852) | University of California, San Francisco | 2004-10-01 |
| Title XELOX FOR SALIVARY GLAND CANCERS (NCT00101075) | Dana-Farber Cancer Institute | 2004-10-01 |
| Study of D-Methadone in Patients With Chronic Pain (NCT00588640) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer (NCT00103155) | University of California, San Francisco | 2004-09-01 |
| NGR-TNF in Treating Patients With Advanced Solid Tumors (NCT00098943) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-09-01 |
| Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00352391) | M.D. Anderson Cancer Center | 2004-08-01 |
| Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) (NCT00095875) | Dana-Farber Cancer Institute | 2004-08-01 |
| Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib (NCT00820417) | Harrison Clinical Research | 2004-06-01 |
| Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma (NCT00198315) | Inovio Pharmaceuticals | 2004-06-01 |
| Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients (NCT00606294) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| Capecitabine For Nasopharyngeal Cancer (NCT00095901) | Dana-Farber Cancer Institute | 2004-06-01 |
| Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx (NCT00243113) | Aichi Cancer Center | 2004-06-01 |
| Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00415025) | University of Wisconsin, Madison | 2004-06-01 |
| Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma (NCT00228488) | AstraZeneca | 2004-06-01 |
| Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT00083057) | National Institutes of Health Clinical Center (CC) | 2004-05-01 |
| A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC (NCT00483821) | Vanderbilt-Ingram Cancer Center | 2004-05-01 |
| Doxil Topotecan Doublet Cancer Study (NCT00252889) | Christiana Care Health Services | 2004-05-01 |
| Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) (NCT00077051) | University of Miami | 2004-04-01 |
| Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer (NCT00195078) | Weill Medical College of Cornell University | 2004-04-01 |
| Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck (NCT00084318) | Radiation Therapy Oncology Group | 2004-04-01 |
| Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00079053) | NCIC Clinical Trials Group | 2004-03-02 |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer (NCT00482872) | Vanderbilt University Medical Center | 2004-03-01 |
| Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck (NCT00216138) | Hoosier Cancer Research Network | 2004-03-01 |
| PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery (NCT00276523) | M.D. Anderson Cancer Center | 2004-02-01 |
| Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer (NCT00448552) | University of Miami | 2004-02-01 |
| Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors (NCT00096707) | Threshold Pharmaceuticals | 2004-02-01 |
| Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer (NCT00568360) | Stanford University | 2004-02-01 |
| Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer (NCT00681967) | AstraZeneca | 2004-02-01 |
| OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer (NCT00076310) | M.D. Anderson Cancer Center | 2004-01-28 |
| A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck (NCT00203905) | University of Chicago | 2004-01-01 |
| Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia (NCT00081029) | Royal Marsden NHS Foundation Trust | 2004-01-01 |
| Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer (NCT01024101) | Bristol-Myers Squibb | 2004-01-01 |
| Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer (NCT00198263) | Inovio Pharmaceuticals | 2004-01-01 |
| Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer (NCT00064298) | Wake Forest University Health Sciences | 2004-01-01 |
| Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo (NCT00258310) | Barbara Ann Karmanos Cancer Institute | 2003-12-01 |
| Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors (NCT00466856) | Vanderbilt-Ingram Cancer Center | 2003-12-01 |